Sandler Capital Management’s Standard BioTools LAB Stock Holding History

Sandler Capital Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-128,486	Closed	-$3.11M	–	163
2015 Q2	$3.11M	Sell	128,486 -115,735	-47%	-$3.65M	0.28%	120
2015 Q1	$10.3M	Buy	244,221 +940	+0.4%	+$37.2K	0.63%	50
2014 Q4	$8.21M	Buy	243,281 +61,500	+34%	+$1.74M	0.43%	79
2014 Q3	$4.45M	Sell	181,781 -141,919	-44%	-$3.99M	0.21%	140
2014 Q2	$9.52M	Sell	323,700 -223,600	-41%	-$7.16M	0.4%	100
2014 Q1	$24.1M	Buy	547,300 +201,600	+58%	+$8.87M	0.85%	43
2013 Q4	$13.2M	Buy	+345,700	New	+$10.2M	0.43%	97

Other funds holding LAB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sandler Capital Management's LAB Position: Q3 2015 in Review

Sandler Capital Management sold out of Standard BioTools (LAB) in Q3 2015, closing a stake of 128,486 shares — an estimated $3.11M sold.

Sandler Capital Management first reported a position in LAB in Q4 2013 and held it in 7 quarters. The position peaked at $24.1M in Q1 2014. 109 funds tracked by Wall St. Rank hold LAB as of Q3 2015.

Sandler Capital Management reported no remaining Standard BioTools position as of Q3 2015 after selling out during the quarter.
Sandler Capital Management sold 128,486 Standard BioTools shares in Q3 2015, an estimated $3.11M.
Sandler Capital Management first reported a position in Standard BioTools in Q4 2013 and held it in 7 quarters.
Sandler Capital Management's Standard BioTools position peaked at $24.1M in Q1 2014.
109 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2015.

Based on Sandler Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.